{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,8,11]],"date-time":"2024-08-11T10:32:10Z","timestamp":1723372330482},"reference-count":1,"publisher":"Oxford University Press (OUP)","issue":"S2","license":[{"start":{"date-parts":[[2021,1,5]],"date-time":"2021-01-05T00:00:00Z","timestamp":1609804800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,2,1]]},"abstract":"<jats:p>Nearly half (48%) of patients with active breast cancer or a history of breast cancer and COVID-19 were hospitalized and 9% died within 30 days of COVID-19 diagnosis, according to new data from the COVID-19 and Cancer Consortium registry study.<\/jats:p>","DOI":"10.1002\/onco.13664","type":"journal-article","created":{"date-parts":[[2021,1,6]],"date-time":"2021-01-06T01:54:39Z","timestamp":1609898079000},"page":"S17-S18","source":"Crossref","is-referenced-by-count":2,"title":["Registry Study Describes COVID-19 Mortality and Hospitalization in Patients with Breast Cancer"],"prefix":"10.1093","volume":"26","member":"286","published-online":{"date-parts":[[2021,1,5]]},"reference":[{"key":"2021122511545147100_onco13664-bib-0001","volume-title":"Characteristics and outcomes of SARS-CoV-2 infection in patients with invasive breast cancer (BC) from the COVID-19 and Cancer Consortium (CCC19) Cohort Study. Presented at the 2020 San Antonio Breast Cancer Symposium (SABCS). December 8\u201311","author":"Khaki","year":"2020"}],"container-title":["The Oncologist"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/onco.13664","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/onco.13664","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/oncolo\/article-pdf\/26\/S2\/S17\/41923145\/oncolo_26_s2_s17.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/oncolo\/article-pdf\/26\/S2\/S17\/41923145\/oncolo_26_s2_s17.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,25]],"date-time":"2021-12-25T11:57:25Z","timestamp":1640433445000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/oncolo\/article\/26\/S2\/S17\/6445605"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,5]]},"references-count":1,"journal-issue":{"issue":"S2","published-online":{"date-parts":[[2021,1,5]]},"published-print":{"date-parts":[[2021,2,1]]}},"URL":"https:\/\/doi.org\/10.1002\/onco.13664","relation":{},"ISSN":["1083-7159","1549-490X"],"issn-type":[{"value":"1083-7159","type":"print"},{"value":"1549-490X","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,2,1]]},"published":{"date-parts":[[2021,1,5]]}}}